Related Experiment Video
Updated: May 25, 2026

11:01
Preparation and In Vivo Use of an Activity-based Probe for N-acylethanolamine Acid Amidase
Published on: November 23, 2016
Development of a highly selective, orally bioavailable and CNS penetrant M1 agonist derived from the MLPCN probe
Evan P Lebois1, Gregory J Digby, Douglas J Sheffler
1Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Bioorganic & Medicinal Chemistry Letters
|September 21, 2011
Abstract:
Herein we report the discovery and SAR of a novel series of M(1) agonists based on the MLPCN probe, ML071. From this, VU0364572 emerged as a potent, orally bioavailable and CNS penetrant M(1) agonist with high selectivity, clean ancillary pharmacology and enantiospecific activity.

![Technical Aspect of the Automated Synthesis and Real-Time Kinetic Evaluation of [11C]SNAP-7941](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F59557.jpg&w=3840&q=50)